Filtros de búsqueda

Lista de obras de

90Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma ⬇️

artículo científico publicado el 24 de enero de 2011

A mixed methods approach to developing and evaluating oncology trainee education around minimization of adverse events and improved patient quality and safety.

artículo científico publicado en 2016

A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphoma

artículo científico publicado en 2016

A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

artículo científico publicado en 2013

A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

artículo científico publicado en 2015

A prospective study of minimal residual disease in patients with diffuse large B-cell lymphoma using an Ig-NGS assay

artículo científico publicado en 2020

AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 01 February 2019

Adolescent and young adult lymphoma: collaborative efforts toward optimizing care and improving outcomes

artículo científico publicado en 2017

Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome

artículo científico publicado en 2008

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

artículo científico publicado en 2013

Antibody and immunomodulatory agents in the treatment of indolent non-Hodgkin's lymphoma

scientific article published on April 2008

Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility

artículo científico publicado en 2018

Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis

artículo científico publicado en 2017

Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma.

artículo científico publicado en 2011

Biology of double-hit B-cell lymphomas

artículo científico publicado en 2012

Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma ⬇️

artículo científico publicado el 28 de diciembre de 2010

Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403 ⬇️

artículo científico publicado en 2020

Brentuximab Vedotin for Stage III or IV Hodgkin’s Lymphoma

artículo científico publicado en 2018

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma.

artículo científico publicado en 2018

Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma

scientific article published on 11 June 2019

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma

scientific article published on 01 November 2018

Cancer Treatment-Related Infertility: A Critical Review of the Evidence

artículo científico publicado en 2019

Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology

artículo científico publicado en 2018

Cardiac Presentation of Anaplastic Large-Cell Lymphoma

artículo científico publicado en 2010

Case 25-2017.

artículo científico publicado en 2017

Characteristics and outcomes after autologous stem cell transplant for patients with relapsed or refractory diffuse large B-cell lymphoma who failed initial rituximab, cyclophosphamide, adriamycin, vincristine, and prednisone therapy compared to pat

artículo científico publicado en 2010

Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015

artículo científico publicado en 2015

Clinical and pathological prognostic markers for survival in adult patients with post-transplant lymphoproliferative disorders in solid transplant

artículo científico publicado en 2008

Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation

scientific article published on 21 September 2010

Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.

artículo científico publicado en 2017

Combined Modality Treatment for PET-Positive Non-Hodgkin Lymphoma: Favorable Outcomes of Combined Modality Treatment for Patients With Non-Hodgkin Lymphoma and Positive Interim or Postchemotherapy FDG-PET ⬇️

artículo científico publicado el 18 de mayo de 2012

Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database

artículo científico publicado en 2012

Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network

artículo científico publicado en 2014

Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network

artículo científico publicado en 2008

Current considerations in AYA Hodgkin lymphoma

artículo científico publicado en 2018

Cutaneous Eruptions from Ibrutinib Resembling EGFR Inhibitor-Induced Dermatologic Adverse Events

artículo científico publicado en 2019

Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes

scientific article published on 06 July 2016

Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma

artículo científico publicado en 2013

Diffuse Large B-Cell Lymphoma Version 1.2016

scientific article published on 01 February 2016

Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study

artículo científico publicado en 2018

Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET

artículo científico publicado en 2011

End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin’s lymphoma ⬇️

artículo científico publicado el 15 de octubre de 2010

Enzastaurin

artículo científico publicado en 2008

Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders

Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis ⬇️

artículo científico publicado el 21 de febrero de 2011

Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma

artículo científico publicado en 2012

Evidence-Based Minireview: What is the optimal timing of anti-PD-1 antibodies in relapsed classical Hodgkin lymphoma?

artículo científico publicado en 2019

Excellent Outcomes Following Response-based Omission of Radiotherapy in Children and Adolescents With Intermediate or High-risk Hodgkin Lymphoma

artículo científico publicado en 2018

Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma

scientific article published on 01 January 2007

Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma

scientific article published on 01 October 2019

Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma.

artículo científico publicado en 2011

High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex

artículo científico publicado en 2016

High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database.

artículo científico publicado en 2012

Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability.

artículo científico publicado en 2015

How I treat Burkitt lymphoma in adults

artículo científico publicado en 2014

How to Approach a Patient With Limited Stage Hodgkin Lymphoma Who Remains PET Positive at the End of Chemotherapy: Radiation Therapy?

artículo científico publicado en 2017

Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy

artículo científico publicado en 2017

Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial

scientific article published on 14 June 2019

Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphoma.

artículo científico publicado en 2014

Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.

artículo científico publicado en 2009

Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning

artículo científico publicado en 2008

Improving the quality of bone marrow assessment: Impact of operator techniques and use of a specimen preparation checklist

artículo científico publicado en 2013

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

artículo científico publicado en 2010

Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?

artículo científico publicado en 2012

Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma

artículo científico publicado en 2017

Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: findings from a large national database.

artículo científico publicado en 2011

Large vessel vasculopathy in Epstein-Barr virus-positive diffuse large B-cell lymphoma

artículo científico publicado en 2013

Limited stage diffuse large B-cell lymphoma: comparative effectiveness of treatment strategies in a large cohort of elderly patients

artículo científico publicado en 2014

Long-Term Complications of Lymphoma and Its Treatment ⬇️

artículo científico publicado el 11 de abril de 2011

Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma.

artículo científico publicado en 2017

Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation

artículo científico publicado en 2013

Lymphoma: risk and response after solid organ transplant

artículo científico publicado el 1 de septiembre de 2010

NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas

artículo científico publicado en 2010

NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019

scientific article published on 01 June 2019

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017.

artículo científico publicado en 2017

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

artículo científico publicado en 2016

NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes

artículo científico publicado en 2005

Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity ⬇️

artículo científico publicado el 18 de noviembre de 2010

Nodular lymphocyte predominant Hodgkin lymphoma

artículo científico publicado en 2009

Non-Hodgkin's Lymphomas, version 3.2012

artículo científico publicado en 2012

Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology

artículo científico publicado en 2006

Non-Hodgkin's lymphomas

artículo científico publicado en 2008

Non-Hodgkin's lymphomas

artículo científico publicado en 2011

Non-Hodgkin's lymphomas, version 1.2013.

artículo científico publicado en 2013

Non-Hodgkin's lymphomas, version 2.2014

artículo científico publicado en 2014

Non-Hodgkin's lymphomas, version 4.2014.

artículo científico publicado en 2014

Novel agents and immune invasion in Hodgkin lymphoma

scientific article published on 01 December 2019

Ofatumumab plus high dose methylprednisolone followed by ofatumumab plus alemtuzumab to achieve maximal cytoreduction prior to allogeneic transplantation for 17p deleted or TP53 mutated chronic lymphocytic leukemia

artículo científico publicado en 2018

Outcome in Patients With Myelodysplastic Syndrome After Autologous Bone Marrow Transplantation for Non-Hodgkin's Lymphoma

article

Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.

artículo científico publicado en 2017

Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens

artículo científico publicado en 2009

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

scientific article published on 01 January 2020

PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma

artículo científico publicado en 2017

PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

scientific article published on 05 April 2019

Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1-2 follicular lymphoma and its impact on initial treatment strategy in the National Comprehensive Cancer Network Non-Hodgkin Lymphoma Outcomes

scientific article published on 25 February 2013

Phase 1 trial of bortezomib plus R‐CHOP in previously untreated patients with aggressive non‐Hodgkin lymphoma ⬇️

artículo científico publicado el 27 de julio de 2010

Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lympho

artículo científico publicado en 2014

Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia ⬇️

artículo científico publicado el 14 de marzo de 2011

Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma

artículo científico publicado en 2007

Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL

artículo científico publicado en 2018

Post-transplant lymphoproliferative disorders

scientific article published on 01 June 2006

Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy

scientific article published on 20 October 2011

Preparing Fellows for Graduation: Perspectives on Career Guidance

artículo científico publicado en 2019

Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation

artículo científico

Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders

artículo científico publicado en 2008

Primary mediastinal large B-cell lymphoma

artículo científico publicado en 2009

Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era

scientific article published on 29 December 2012

Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy.

artículo científico publicado en 2009

Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition

artículo científico publicado en 2019

Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project

artículo científico publicado en 2014

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation

artículo científico

Reliability of staging, prognosis, and comorbidity data collection in the National Comprehensive Cancer Network (NCCN) non-Hodgkin lymphoma (NHL) multicenter outcomes database

artículo científico publicado en 2008

Reply to H.J.A. Adams et al

artículo científico publicado en 2018

Response-Adapted Therapy in Aggressive Lymphoma: Not Yet Ready for Clinical Care

artículo científico publicado en 2018

Richter's Transformation of Chronic Lymphocytic Leukemia ⬇️

artículo científico publicado el 10 de enero de 2011

Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant ⬇️

artículo científico publicado el 3 de enero de 2012

Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma

scientific article published on 01 March 2020

Role of 2-Deoxy-2-[18F]-fluoro-d-glucose-PET/Computed Tomography in Lymphoma

artículo científico

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma

artículo científico publicado en 2012

Spatial Signatures Identify Immune Escape via PD-1 as a Defining Feature of T-cell/Histiocyte-rich Large B-cell Lymphoma

scientific article published on 01 September 2020

Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project.

artículo científico publicado en 2013

Suicide in European Hodgkin Lymphoma Patients

artículo científico publicado en 2019

Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis

artículo científico publicado en 2010

Targeting Epstein-Barr virus-associated lymphomas

artículo científico publicado en 2014

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

artículo científico publicado en 2016

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

artículo científico publicado en 2016

The epidemiology of herpes zoster and its complications in Medicare cancer patients.

artículo científico publicado en 2015

The treatment of Burkitt lymphoma in adults

artículo científico publicado en 2020

Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501)

artículo científico publicado en 2014

Three-year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphoma

artículo científico publicado en 2020

Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database

artículo científico publicado en 2013

Treating Hodgkin lymphoma in the new millennium: Relapsed and refractory disease

artículo científico publicado en 2019

Treatment of favorable, limited-stage Hodgkin's lymphoma with chemotherapy without consolidation by radiation therapy

artículo científico publicado en 2010

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.

scientific article published on 11 April 2016

Update on the therapy of highly aggressive non-Hodgkin's lymphoma

artículo científico publicado en 2006

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda